Skip to main content
. 2023 Jul 20;10(8):ofad383. doi: 10.1093/ofid/ofad383

Table 2.

Descriptive Summary of Clostridioides difficile Health-Related Quality-of-Life Survey Scores at Baseline and Weeks 1, 4, and 8

Cdiff32 Domain Cdiff32 Score, Mean (SD)a Difference in Change From Baseline to wk 8
Baseline wk 1 wk 4 wk 8
Placebo
(n = 57)
RBL
(n = 128)
Placebo
(n = 76)
RBL
(n = 168)
Placebo
(n = 61)
RBL
(n = 135)
Placebo
(n = 57)
RBL
(n = 128)
Total 43.6 (21.3) 44.2 (17.5) 57.6 (21.3) 61.6 (18.3) 68.0 (22.4) 71.7 (18.7) 69.2 (24.0) 75.8 (18.1) 6.0 (3.4) (P = .12)
Physical 50.8 (23.5) 53.2 (21.3) 68.2 (22.5) 73.3 (18.4) 74.6 (23.7) 81.0 (17.2) 78.0 (23.0) 84.4 (16.7) 4.1 (3.8) (P = .30)
Mental 34.5 (21.5) 33.0 (16.9) 46.0 (23.1) 48.8 (21.6) 59.0 (24.4) 61.5 (22.7) 59.4 (27.3) 66.3 (21.8) 8.5 (3.7) (P < .05)
Social 50.1 (26.8) 53.5 (23.4) 61.4 (26.2) 66.1 (23.2) 71.7 (27.5) 75.5 (22.3) 73.0 (28.0) 80.1 (21.1) 3.6 (4.4) (P = .51)

Abbreviations: Cdiff32, Clostridioides difficile Health-related Quality-of-Life Survey; RBL, fecal microbiota, live-jslm (REBYOTA; Rebiotix).

a

The sample size at baseline was restricted to patients who also had data at week 8. The sample size at week 1 was restricted to patients with both baseline and week 1 data, and the sample size at week 4 to patients with both baseline and week 4 data.